BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15161727)

  • 1. Use of PCR-based amplification analysis as a substitute for the southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia.
    Lee HH; Lee YJ; Chan P; Lin CY
    Clin Chem; 2004 Jun; 50(6):1074-6. PubMed ID: 15161727
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency.
    Asanuma A; Ohura T; Ogawa E; Sato S; Igarashi Y; Matsubara Y; Iinuma K
    J Hum Genet; 1999; 44(5):312-7. PubMed ID: 10496074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese.
    Lee HH; Kuo JM; Chao HT; Lee YJ; Chang JG; Tsai CH; Chung BC
    J Clin Endocrinol Metab; 2000 Feb; 85(2):597-600. PubMed ID: 10690861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia.
    Lee HH; Chao HT; Ng HT; Choo KB
    J Med Genet; 1996 May; 33(5):371-5. PubMed ID: 8733045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia using the polymerase chain reaction.
    Owerbach D; Draznin MB; Carpenter RJ; Greenberg F
    Hum Genet; 1992 Apr; 89(1):109-10. PubMed ID: 1349559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency.
    Bachega TA; Billerbeck AE; Madureira G; Arnhold IJ; Medeiros MA; Marcondes JA; Longui CA; Nicolau W; Bloise W; Mendonca BB
    Hum Hered; 1999 Jan; 49(1):9-14. PubMed ID: 10189236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency.
    Tukel T; Uyguner O; Wei JQ; Yuksel-Apak M; Saka N; Song DX; Kayserili H; Bas F; Gunoz H; Wilson RC; New MI; Wollnik B
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5893-7. PubMed ID: 14671187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duplication of 111 bases in exon 1 of the CYP21 gene is combined with deletion of CYP21P-C4B genes in steroid 21-hydroxylase deficiency.
    Lee HH; Chang SF; Lo FS; Chao HT; Lin CY
    Mol Genet Metab; 2003 Jul; 79(3):214-20. PubMed ID: 12855227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP21 mutations and congenital adrenal hyperplasia.
    Lee HH
    Clin Genet; 2001 May; 59(5):293-301. PubMed ID: 11359457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: molecular analysis of congenital adrenal hyperplasia in a newborn screening program.
    Killeen AA
    Mol Diagn; 2001 Sep; 6(3):189-91. PubMed ID: 11571712
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical congenital adrenal hyperplasia.
    Dardis A; Bergada I; Bergada C; Rivarola M; Belgorosky A
    J Pediatr Endocrinol Metab; 1997; 10(1):55-61. PubMed ID: 9364343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
    Owerbach D; Ballard AL; Draznin MB
    J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kirby-Keyser L; Porter CC; Donohoue PA
    Hum Mutat; 1997; 9(2):181-2. PubMed ID: 9067760
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
    Liao XY; Zhang YF; Gu XF
    Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening method for detecting mutations in the 21-hydroxylase gene.
    Oriola J; Plensa I; Machuca I; Pavía C; Rivera-Fillat F
    Clin Chem; 1997 Apr; 43(4):557-61. PubMed ID: 9105254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study.
    Manfras BJ; Swinyard M; Rudert WA; Ball EJ; Lee PA; Kühnl P; Trucco M; Böhm BO
    Hum Genet; 1993 Aug; 92(1):33-9. PubMed ID: 8365724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid 21-hydroxylase expression and activity in human lymphocytes.
    Zhou Z; Agarwal VR; Dixit N; White P; Speiser PW
    Mol Cell Endocrinol; 1997 Mar; 127(1):11-8. PubMed ID: 9099896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
    Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
    BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in steroid 21-hydroxylase (CYP21).
    White PC; Tusie-Luna MT; New MI; Speiser PW
    Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.